Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PCOS Sisters vs Queen RX

PCOS Sisters
Graded #219

Lower grade

vs+0.29999999999999716
Queen RX
Graded #212

Higher grade

The verdict

Queen RX takes it — 66/100 to 65.7/100, but only just.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo). PCOS Sisters is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +15
61
76
Dose & formulationPCOS Sisters +31
88
57
Clinical oversightPCOS Sisters +1
70
69
Labs & monitoringQueen RX +1
52
53
FulfillmentQueen RX +10
65
75
Contract termsQueen RX +20
41
61
PCOS Sisters · left barQueen RX · right bar

The numbers

MetricPCOS SistersQueen RX
WeighScore65.7/10066/100
GradeCC
Scorecard rank#219#212
Semaglutide$150/mo (plus a separate fee, compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$150/mo (plus a separate fee, compounded)Not disclosed
Coverage12 states45 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
PCOS Sisters

Graded #219 · C

Strengths

  • Dedicated PCOS specialty model with metabolic program and fitness app included
  • Transparent 150 dollars per month GLP-1 management fee
  • Names real partner pharmacies (Strive, Striker) and lists phone support

Where it loses points

  • Only 12 states served
  • Membership required on top of the medical program
  • Unclear whether pharmacy dispensing fees are separate from the 150/mo fee
Queen RX

Graded #212 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard